| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |